低剂量阿比拉酸用于治疗前列腺癌:一项观察性队列研究

Luis Angel Di-Giuseppe1, Rodney Alexander Ramirez-Murillo2, Mariano Daniel Aymar2

  • 1Department of Pharmacology-Toxicology, University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Pharmacy and Supplies Area, Health Insurance Provider of the Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

概括

在转移性前列腺癌患者中,低剂量阿比拉乙酸的无进展生存期与标准剂量相比相当. 这一发现表明,有潜力改善治疗的可访问性,并具有类似的疗效.